Chemcon Speciality Chemicals Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: April 18, 2025, 10:00 pm

Market Cap	714 Cr.
Current Price	195
High / Low	298/160
Stock P/E	30.5
Book Value	133
Dividend Yield	0.00 %
ROCE	5.71 %
ROE	4.11 %
Face Value	10.0
PEG Ratio	-1.89

Stock P/E, Current Price, and Intrinsic Value Over Time

Stock P/E Current Price Intrinsic Value

View Share Price Target for Chemcon Speciality Chemicals Ltd

Competitors of Chemcon Speciality Chemicals Ltd

Stock Name ⇩	Market Cap ⇩	Current Price ⇩	High / Low ⇩	Stock P/E ⇩	Book Value ⇩	Dividend Yield ⇩	ROCE ⇩	ROE ⇩	Face Value ⇩
HP Adhesives Ltd	517 Cr.	56.3	109/42.6	26.8	19.2	0.53 %	17.7 %	12.6 %	2.00
Haryana Leather Chemicals Ltd	37.9 Cr.	77.3	124/62.6	9.21	87.2	1.29 %	8.96 %	7.25 %	10.0
Hardcastle & Waud Mfg Co Ltd	50.7 Cr.	745	1,355/600	29.0	663	0.00 %	7.00 %	5.98 %	10.0
Grauer & Weil (India) Ltd	3,891 Cr.	85.8	120/72.2	24.2	19.2	0.58 %	26.1 %	19.6 %	1.00
DMCC Speciality Chemicals Ltd	727 Cr.	292	453/241	34.9	85.4	0.34 %	7.55 %	2.89 %	10.0
Industry Average	12,596.28 Cr	704.72		48.95	173.82	0.38%	13.99%	10.73%	6.44

All Competitor Stocks of Chemcon Speciality Chemicals Ltd

Quarterly Result

Metric	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024
Sales	49.54	89.13	89.41	57.92	76.47	79.08	79.33	75.19	52.98	59.59	45.52	52.60	54.39
Expenses	32.21	61.67	55.86	48.33	62.98	65.02	71.62	66.86	46.64	55.21	38.40	44.09	43.10
Operating Profit	17.33	27.46	33.55	9.59	13.49	14.06	7.71	8.33	6.34	4.38	7.12	8.51	11.29
OPM %	34.98%	30.81%	37.52%	16.56%	17.64%	17.78%	9.72%	11.08%	11.97%	7.35%	15.64%	16.18%	20.76%
Other Income	2.33	2.72	2.68	3.29	4.46	2.89	3.59	3.03	3.34	3.34	3.76	3.50	4.01
Interest	0.11	0.08	0.16	0.25	0.59	0.49	0.68	0.73	1.04	1.05	0.99	0.93	0.74
Depreciation	1.55	1.70	1.93	2.05	2.14	2.26	2.62	2.59	2.58	2.51	2.53	2.55	2.71
Profit before tax	18.00	28.40	34.14	10.58	15.22	14.20	8.00	8.04	6.06	4.16	7.36	8.53	11.85
Tax %	25.11%	25.04%	25.42%	25.99%	25.36%	26.27%	26.25%	26.12%	26.73%	30.05%	27.17%	25.79%	25.74%
Net Profit	13.49	21.29	25.46	7.82	11.36	10.47	5.91	5.94	4.44	2.90	5.37	6.33	8.81
EPS in Rs	3.68	5.81	6.95	2.13	3.10	2.86	1.61	1.62	1.21	0.79	1.47	1.73	2.41

Last Updated: March 3, 2025, 5:01 pm

Below is a detailed analysis of the quarterly data for Chemcon Speciality Chemicals Ltd based on the most recent figures (Dec 2024) and their trends compared to the previous period:

For Sales, as of Dec 2024, the value is 54.39 Cr.. The value appears strong and on an upward trend. It has increased from 52.60 Cr. (Sep 2024) to 54.39 Cr., marking an increase of 1.79 Cr..
For Expenses, as of Dec 2024, the value is 43.10 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 44.09 Cr. (Sep 2024) to 43.10 Cr., marking a decrease of 0.99 Cr..
For Operating Profit, as of Dec 2024, the value is 11.29 Cr.. The value appears strong and on an upward trend. It has increased from 8.51 Cr. (Sep 2024) to 11.29 Cr., marking an increase of 2.78 Cr..
For OPM %, as of Dec 2024, the value is 20.76%. The value appears strong and on an upward trend. It has increased from 16.18% (Sep 2024) to 20.76%, marking an increase of 4.58%.
For Other Income, as of Dec 2024, the value is 4.01 Cr.. The value appears strong and on an upward trend. It has increased from 3.50 Cr. (Sep 2024) to 4.01 Cr., marking an increase of 0.51 Cr..
For Interest, as of Dec 2024, the value is 0.74 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.93 Cr. (Sep 2024) to 0.74 Cr., marking a decrease of 0.19 Cr..
For Depreciation, as of Dec 2024, the value is 2.71 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 2.55 Cr. (Sep 2024) to 2.71 Cr., marking an increase of 0.16 Cr..
For Profit before tax, as of Dec 2024, the value is 11.85 Cr.. The value appears strong and on an upward trend. It has increased from 8.53 Cr. (Sep 2024) to 11.85 Cr., marking an increase of 3.32 Cr..
For Tax %, as of Dec 2024, the value is 25.74%. The value appears to be improving (decreasing) as expected. It has decreased from 25.79% (Sep 2024) to 25.74%, marking a decrease of 0.05%.
For Net Profit, as of Dec 2024, the value is 8.81 Cr.. The value appears strong and on an upward trend. It has increased from 6.33 Cr. (Sep 2024) to 8.81 Cr., marking an increase of 2.48 Cr..
For EPS in Rs, as of Dec 2024, the value is 2.41. The value appears strong and on an upward trend. It has increased from 1.73 (Sep 2024) to 2.41, marking an increase of 0.68.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: March 6, 2025, 4:35 pm

Metric	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	TTM
Sales	51	53	63	97	88	158	303	262	243	257	303	267	212
Expenses	46	46	56	87	79	112	237	192	162	175	232	240	181
Operating Profit	5	6	8	10	9	46	66	70	81	82	71	27	31
OPM %	10%	12%	12%	10%	10%	29%	22%	27%	33%	32%	23%	10%	15%
Other Income	0	0	-1	0	0	0	2	4	5	9	13	13	15
Interest	2	2	2	3	2	3	4	5	4	1	1	4	4
Depreciation	1	1	2	2	2	2	3	5	6	6	8	10	10
Profit before tax	3	3	3	5	5	41	61	65	76	84	74	26	32
Tax %	33%	60%	3%	35%	37%	35%	30%	25%	26%	25%	26%	27%
Net Profit	2	1	3	3	3	26	43	49	56	63	55	19	23
EPS in Rs	2.11	1.46	3.35	4.09	3.78	33.21	13.54	15.37	15.40	17.13	15.04	5.24	6.40
Dividend Payout %	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	27%	0%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year	2013-2014	2014-2015	2015-2016	2016-2017	2017-2018	2018-2019	2019-2020	2020-2021	2021-2022	2022-2023	2023-2024
YoY Net Profit Growth (%)	-50.00%	200.00%	0.00%	0.00%	766.67%	65.38%	13.95%	14.29%	12.50%	-12.70%	-65.45%
Change in YoY Net Profit Growth (%)	0.00%	250.00%	-200.00%	0.00%	766.67%	-701.28%	-51.43%	0.33%	-1.79%	-25.20%	-52.76%

Chemcon Speciality Chemicals Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2013-2014 to 2023-2024.

Growth

Compounded Sales Growth
10 Years:	18%
5 Years:	-3%
3 Years:	3%
TTM:	-26%

Compounded Profit Growth
10 Years:	32%
5 Years:	-15%
3 Years:	-30%
TTM:	-13%

Stock Price CAGR
10 Years:	%
5 Years:	%
3 Years:	-17%
1 Year:	-22%

Return on Equity
10 Years:	17%
5 Years:	15%
3 Years:	11%
Last Year:	4%

Last Updated: Unknown

Balance Sheet

Last Updated: November 15, 2024, 1:31 am

Month	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Sep 2024
Equity Capital	8	8	8	8	8	8	32	32	37	37	37	37	37
Reserves	10	11	13	16	19	46	65	115	317	381	421	440	451
Borrowings	13	14	12	13	20	17	33	46	6	36	64	43	43
Other Liabilities	6	12	10	9	15	27	43	34	44	45	32	26	29
Total Liabilities	37	45	44	46	63	97	173	226	404	498	553	545	561
Fixed Assets	14	20	20	19	24	30	40	49	67	82	141	146	143
CWIP	1	0	0	0	0	0	1	4	9	34	14	42	48
Investments	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Assets	22	25	24	27	38	67	133	173	328	382	398	356	369
Total Assets	37	45	44	46	63	97	173	226	404	498	553	545	561

Below is a detailed analysis of the balance sheet data for Chemcon Speciality Chemicals Ltd based on the most recent figures (Sep 2024) and their trends compared to the previous period:

For Equity Capital, as of Sep 2024, the value is ₹37.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 37.00 Cr..
For Reserves, as of Sep 2024, the value is ₹451.00 Cr.. The value appears strong and on an upward trend. It has increased from 440.00 Cr. (Mar 2024) to ₹451.00 Cr., marking an increase of 11.00 Cr..
For Borrowings, as of Sep 2024, the value is ₹43.00 Cr.. The value remains steady. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. There is no change compared to the previous period (Mar 2024) which recorded 43.00 Cr..
For Other Liabilities, as of Sep 2024, the value is ₹29.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 26.00 Cr. (Mar 2024) to ₹29.00 Cr., marking an increase of 3.00 Cr..
For Total Liabilities, as of Sep 2024, the value is ₹561.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 545.00 Cr. (Mar 2024) to ₹561.00 Cr., marking an increase of 16.00 Cr..
For Fixed Assets, as of Sep 2024, the value is ₹143.00 Cr.. The value appears to be declining and may need further review. It has decreased from 146.00 Cr. (Mar 2024) to ₹143.00 Cr., marking a decrease of 3.00 Cr..
For CWIP, as of Sep 2024, the value is ₹48.00 Cr.. The value appears strong and on an upward trend. It has increased from 42.00 Cr. (Mar 2024) to ₹48.00 Cr., marking an increase of 6.00 Cr..
For Investments, as of Sep 2024, the value is ₹0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
For Other Assets, as of Sep 2024, the value is ₹369.00 Cr.. The value appears strong and on an upward trend. It has increased from 356.00 Cr. (Mar 2024) to ₹369.00 Cr., marking an increase of 13.00 Cr..
For Total Assets, as of Sep 2024, the value is ₹561.00 Cr.. The value appears strong and on an upward trend. It has increased from 545.00 Cr. (Mar 2024) to ₹561.00 Cr., marking an increase of 16.00 Cr..

Notably, the Reserves (451.00 Cr.) exceed the Borrowings (43.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Reserves and Borrowings Chart

Cash Flow

Month	Mar 2013	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Cash from Operating Activity +	3	7	5	10	14	11	12	65	74	13	12
Cash from Investing Activity +	-4	-5	-2	-9	-7	-24	-16	-152	-92	-16	-25
Cash from Financing Activity +	0	-3	-3	-2	-6	12	4	111	30	12	-25
Net Cash Flow	-0	-1	-0	-1	1	-0	0	23	11	9	-37

Free Cash Flow

Month	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Free Cash Flow	-8.00	-8.00	-4.00	-3.00	-11.00	29.00	33.00	24.00	75.00	46.00	7.00	-16.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

Month	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Debtor Days	51	40	52	51	93	68	77	124	142	146	81	112
Inventory Days	107	146	74	45	58	99	91	118	175	102	164	119
Days Payable	46	97	79	39	81	82	57	63	67	70	44	23
Cash Conversion Cycle	112	89	47	57	70	86	111	179	250	177	201	208
Working Capital Days	118	85	64	59	79	93	95	175	189	155	184	220
ROCE %	17%	17%	17%	22%	16%	74%	65%	43%	29%	21%	15%	6%

Financial Efficiency Indicators Chart

Share Holding Pattern

Month	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024
Promoters	74.47%	74.47%	74.47%	74.47%	74.47%	74.47%	74.47%	74.47%	74.47%	74.47%	74.47%	74.47%
FIIs	0.09%	0.02%	0.05%	0.02%	0.14%	0.01%	0.10%	0.01%	0.01%	0.05%	0.25%	0.25%
DIIs	1.03%	0.68%	0.28%	0.28%	0.27%	0.27%	0.27%	0.27%	0.27%	0.28%	0.27%	0.27%
Public	24.41%	24.83%	25.21%	25.24%	25.11%	25.25%	25.15%	25.25%	25.24%	25.20%	25.01%	25.01%
No. of Shareholders	85,101	90,235	90,936	90,004	84,064	86,831	86,161	84,711	83,509	81,367	79,108	76,389

Shareholding Pattern Chart

No. of Shareholders

Mutual Fund Holdings

Fund Name	No of Shares	AUM (%)	Amount Invested (Cr)	Previous Number of Shares	Previous Date	Percentage Change
Tata Resources & Energy Fund	100,000	0.27	2.67	N/A	N/A	N/A
Tata Resources & Energy Fund - Direct Plan	100,000	0.27	2.67	N/A	N/A	N/A

ROCE Trend

EPS Trend

Key Financial Ratios

Month	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20
FaceValue	10.00	10.00	10.00	10.00	10.00
Basic EPS (Rs.)	5.24	15.04	17.13	16.48	15.37
Diluted EPS (Rs.)	5.24	15.04	17.13	16.48	15.37
Cash EPS (Rs.)	8.05	17.33	18.84	17.06	16.83
Book Value[Excl.RevalReserv]/Share (Rs.)	130.06	124.86	113.89	96.56	46.06
Book Value[Incl.RevalReserv]/Share (Rs.)	130.06	124.86	113.89	96.56	46.06
Dividend / Share (Rs.)	0.00	4.00	4.00	0.00	0.00
Revenue From Operations / Share (Rs.)	72.91	82.69	70.19	66.47	82.46
PBDIT / Share (Rs.)	10.94	22.93	24.80	23.41	23.36
PBIT / Share (Rs.)	8.12	20.65	23.09	21.75	21.90
PBT / Share (Rs.)	7.17	20.24	22.93	20.76	20.43
Net Profit / Share (Rs.)	5.24	15.04	17.13	15.40	15.37
PBDIT Margin (%)	15.00	27.73	35.32	35.22	28.32
PBIT Margin (%)	11.14	24.97	32.89	32.72	26.56
PBT Margin (%)	9.83	24.48	32.66	31.23	24.77
Net Profit Margin (%)	7.18	18.19	24.40	23.16	18.64
Return on Networth / Equity (%)	4.02	12.04	15.04	15.94	33.37
Return on Capital Employeed (%)	6.17	16.36	20.11	22.23	42.41
Return On Assets (%)	3.52	9.95	12.60	13.97	21.63
Long Term Debt / Equity (X)	0.00	0.00	0.00	0.01	0.10
Total Debt / Equity (X)	0.08	0.13	0.08	0.01	0.30
Asset Turnover Ratio (%)	0.48	0.57	0.57	0.77	1.31
Current Ratio (X)	5.54	3.41	4.84	6.30	2.80
Quick Ratio (X)	4.58	2.55	4.40	4.99	2.02
Inventory Turnover Ratio (X)	2.90	3.30	2.49	2.11	3.26
Dividend Payout Ratio (NP) (%)	0.00	26.58	0.00	0.00	0.00
Dividend Payout Ratio (CP) (%)	0.00	23.08	0.00	0.00	0.00
Earning Retention Ratio (%)	0.00	73.42	0.00	0.00	0.00
Cash Earning Retention Ratio (%)	0.00	76.92	0.00	0.00	0.00
Interest Coverage Ratio (X)	11.46	56.44	159.53	23.61	15.85
Interest Coverage Ratio (Post Tax) (X)	6.49	38.02	111.22	16.52	11.43
Enterprise Value (Cr.)	718.52	773.10	787.64	1372.68	0.00
EV / Net Operating Revenue (X)	2.69	2.55	3.06	5.64	0.00
EV / EBITDA (X)	17.93	9.20	8.67	16.00	0.00
MarketCap / Net Operating Revenue (X)	3.17	2.77	3.80	6.13	0.00
Retention Ratios (%)	0.00	73.41	0.00	0.00	0.00
Price / BV (X)	1.78	1.84	2.34	4.22	0.00
Price / Net Operating Revenue (X)	3.17	2.77	3.80	6.13	0.00
EarningsYield	0.02	0.06	0.06	0.03	0.00

After reviewing the key financial ratios for Chemcon Speciality Chemicals Ltd, here is a detailed analysis based on the latest available data and recent trends:

For FaceValue, as of Mar 24, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 10.00.
For Basic EPS (Rs.), as of Mar 24, the value is 5.24. This value is within the healthy range. It has decreased from 15.04 (Mar 23) to 5.24, marking a decrease of 9.80.
For Diluted EPS (Rs.), as of Mar 24, the value is 5.24. This value is within the healthy range. It has decreased from 15.04 (Mar 23) to 5.24, marking a decrease of 9.80.
For Cash EPS (Rs.), as of Mar 24, the value is 8.05. This value is within the healthy range. It has decreased from 17.33 (Mar 23) to 8.05, marking a decrease of 9.28.
For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 130.06. It has increased from 124.86 (Mar 23) to 130.06, marking an increase of 5.20.
For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 130.06. It has increased from 124.86 (Mar 23) to 130.06, marking an increase of 5.20.
For Dividend / Share (Rs.), as of Mar 24, the value is 0.00. This value is below the healthy minimum of 1. It has decreased from 4.00 (Mar 23) to 0.00, marking a decrease of 4.00.
For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 72.91. It has decreased from 82.69 (Mar 23) to 72.91, marking a decrease of 9.78.
For PBDIT / Share (Rs.), as of Mar 24, the value is 10.94. This value is within the healthy range. It has decreased from 22.93 (Mar 23) to 10.94, marking a decrease of 11.99.
For PBIT / Share (Rs.), as of Mar 24, the value is 8.12. This value is within the healthy range. It has decreased from 20.65 (Mar 23) to 8.12, marking a decrease of 12.53.
For PBT / Share (Rs.), as of Mar 24, the value is 7.17. This value is within the healthy range. It has decreased from 20.24 (Mar 23) to 7.17, marking a decrease of 13.07.
For Net Profit / Share (Rs.), as of Mar 24, the value is 5.24. This value is within the healthy range. It has decreased from 15.04 (Mar 23) to 5.24, marking a decrease of 9.80.
For PBDIT Margin (%), as of Mar 24, the value is 15.00. This value is within the healthy range. It has decreased from 27.73 (Mar 23) to 15.00, marking a decrease of 12.73.
For PBIT Margin (%), as of Mar 24, the value is 11.14. This value is within the healthy range. It has decreased from 24.97 (Mar 23) to 11.14, marking a decrease of 13.83.
For PBT Margin (%), as of Mar 24, the value is 9.83. This value is below the healthy minimum of 10. It has decreased from 24.48 (Mar 23) to 9.83, marking a decrease of 14.65.
For Net Profit Margin (%), as of Mar 24, the value is 7.18. This value is within the healthy range. It has decreased from 18.19 (Mar 23) to 7.18, marking a decrease of 11.01.
For Return on Networth / Equity (%), as of Mar 24, the value is 4.02. This value is below the healthy minimum of 15. It has decreased from 12.04 (Mar 23) to 4.02, marking a decrease of 8.02.
For Return on Capital Employeed (%), as of Mar 24, the value is 6.17. This value is below the healthy minimum of 10. It has decreased from 16.36 (Mar 23) to 6.17, marking a decrease of 10.19.
For Return On Assets (%), as of Mar 24, the value is 3.52. This value is below the healthy minimum of 5. It has decreased from 9.95 (Mar 23) to 3.52, marking a decrease of 6.43.
For Long Term Debt / Equity (X), as of Mar 24, the value is 0.00. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 23) which recorded 0.00.
For Total Debt / Equity (X), as of Mar 24, the value is 0.08. This value is within the healthy range. It has decreased from 0.13 (Mar 23) to 0.08, marking a decrease of 0.05.
For Asset Turnover Ratio (%), as of Mar 24, the value is 0.48. It has decreased from 0.57 (Mar 23) to 0.48, marking a decrease of 0.09.
For Current Ratio (X), as of Mar 24, the value is 5.54. This value exceeds the healthy maximum of 3. It has increased from 3.41 (Mar 23) to 5.54, marking an increase of 2.13.
For Quick Ratio (X), as of Mar 24, the value is 4.58. This value exceeds the healthy maximum of 2. It has increased from 2.55 (Mar 23) to 4.58, marking an increase of 2.03.
For Inventory Turnover Ratio (X), as of Mar 24, the value is 2.90. This value is below the healthy minimum of 4. It has decreased from 3.30 (Mar 23) to 2.90, marking a decrease of 0.40.
For Dividend Payout Ratio (NP) (%), as of Mar 24, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 26.58 (Mar 23) to 0.00, marking a decrease of 26.58.
For Dividend Payout Ratio (CP) (%), as of Mar 24, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 23.08 (Mar 23) to 0.00, marking a decrease of 23.08.
For Earning Retention Ratio (%), as of Mar 24, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 73.42 (Mar 23) to 0.00, marking a decrease of 73.42.
For Cash Earning Retention Ratio (%), as of Mar 24, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 76.92 (Mar 23) to 0.00, marking a decrease of 76.92.
For Interest Coverage Ratio (X), as of Mar 24, the value is 11.46. This value is within the healthy range. It has decreased from 56.44 (Mar 23) to 11.46, marking a decrease of 44.98.
For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 6.49. This value is within the healthy range. It has decreased from 38.02 (Mar 23) to 6.49, marking a decrease of 31.53.
For Enterprise Value (Cr.), as of Mar 24, the value is 718.52. It has decreased from 773.10 (Mar 23) to 718.52, marking a decrease of 54.58.
For EV / Net Operating Revenue (X), as of Mar 24, the value is 2.69. This value is within the healthy range. It has increased from 2.55 (Mar 23) to 2.69, marking an increase of 0.14.
For EV / EBITDA (X), as of Mar 24, the value is 17.93. This value exceeds the healthy maximum of 15. It has increased from 9.20 (Mar 23) to 17.93, marking an increase of 8.73.
For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 3.17. This value exceeds the healthy maximum of 3. It has increased from 2.77 (Mar 23) to 3.17, marking an increase of 0.40.
For Retention Ratios (%), as of Mar 24, the value is 0.00. This value is below the healthy minimum of 30. It has decreased from 73.41 (Mar 23) to 0.00, marking a decrease of 73.41.
For Price / BV (X), as of Mar 24, the value is 1.78. This value is within the healthy range. It has decreased from 1.84 (Mar 23) to 1.78, marking a decrease of 0.06.
For Price / Net Operating Revenue (X), as of Mar 24, the value is 3.17. This value exceeds the healthy maximum of 3. It has increased from 2.77 (Mar 23) to 3.17, marking an increase of 0.40.
For EarningsYield, as of Mar 24, the value is 0.02. This value is below the healthy minimum of 5. It has decreased from 0.06 (Mar 23) to 0.02, marking a decrease of 0.04.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

Fair Value

Fair Value of Chemcon Speciality Chemicals Ltd as of April 20, 2025 is: 136.05

Calculation basis:

Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.

As of April 20, 2025, Chemcon Speciality Chemicals Ltd is Overvalued by 30.23% compared to the current share price 195.00

Intrinsic Value of Chemcon Speciality Chemicals Ltd as of April 20, 2025 is: 114.14

Calculation basis:

Intrinsic value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100) * (1 + EPS CAGR for Last 5 Years)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
EPS CAGR (Compound Annual Growth Rate): Represents the geometric mean growth rate of earnings per share over the last 5 years. It provides insight into the historical growth trajectory of the company's earnings.

This formula allows us to gauge the intrinsic value of the stock by analyzing its fundamental indicators along with EPS growth.

As of April 20, 2025, Chemcon Speciality Chemicals Ltd is Overvalued by 41.47% compared to the current share price 195.00

Last 5 Year EPS CAGR: -16.11%

*Investments are subject to market risks

Strength and Weakness

Strength	Weakness
The stock has a high average ROCE of 28.50%, which is a positive sign. The company has higher reserves (177.31 cr) compared to borrowings (27.69 cr), indicating strong financial stability. The company has shown consistent growth in sales (181.31 cr) and profit (36.77 cr) over the years.	The stock has a high average Working Capital Days of 126.33, which may not be favorable. The stock has a high average Cash Conversion Cycle of 132.25, which may not be favorable.

Stock Analysis

Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Chemcon Speciality Chemicals Ltd:
1. Net Profit Margin: 7.18%
  - Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
2. ROCE: 6.17% (Industry Average ROCE: 13.99%)
  - ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
3. ROE%: 4.02% (Industry Average ROE: 10.73%)
  - ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
4. Interest Coverage Ratio (Post Tax): 6.49
  - Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
5. Quick Ratio: 4.58
  - Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
6. Stock P/E: 30.5 (Industry average Stock P/E: 48.95)
  - Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
7. Total Debt / Equity: 0.08
  - Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
The current analysis is available for review. It's important to conduct thorough research and consider consulting with financial professionals before making any investment decisions.
Stock Rating:

About the Company - Qualitative Analysis

Chemcon Speciality Chemicals Ltd. is a Public Limited Listed company incorporated on 15/12/1988 and has its registered office in the State of Gujarat, India. Company's Corporate Identification Number(CIN) is L24231GJ1988PLC011652 and registration number is 011652. Currently Company is involved in the business activities of Manufacture of organic and inorganic chemical compounds. Company's Total Operating Revenue is Rs. 267.09 Cr. and Equity Capital is Rs. 36.63 Cr. for the Year ended 31/03/2024.

INDUSTRY	ADDRESS	CONTACT
Chemicals - Speciality - Others	Block No 355, Manjusar Kinpad Road, Vadodra Gujarat 391775	investor.relations@cscpl.com http://www.cscpl.com

Management
Name	Position Held
Mr. Kamalkumar Rajendra Aggarwal	Chairman & Managing Director
Mr. Naresh Vijaykumar Goyal	Joint Managing Director
Mr. Rajesh Chimanlal Gandhi	WholeTime Director & CFO
Mr. Rajveer Kamal Aggarwal	Whole Time Director
Mr. Himanshu Prafulchandra Purohit	Whole Time Director
Mr. Navdeep Naresh Goyal	Whole Time Director
Mr. Bharat Chunilal Shah	Independent Director
Mrs. Neelu Atulkumar Shah	Independent Director
Mr. Lalit Ramniklal Mehta	Independent Director
Mr. Pankaj Amritlal Shah	Independent Director
Mr. Ketan Bhailal Shah	Independent Director
Mr. Lalit Devidutt Chaudhary	Independent Director

FAQ

What is the intrinsic value of Chemcon Speciality Chemicals Ltd?

Chemcon Speciality Chemicals Ltd's intrinsic value (as of 20 April 2025) is ₹136.05 — 30.23% lower the current market price of 195.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 714 Cr. market cap, FY2025-2026 high/low of ₹298/160, reserves of 451 Cr, and liabilities of 561 Cr.

What is the Market Cap of Chemcon Speciality Chemicals Ltd?

The Market Cap of Chemcon Speciality Chemicals Ltd is 714 Cr..

What is the current Stock Price of Chemcon Speciality Chemicals Ltd as on 20 April 2025?

The current stock price of Chemcon Speciality Chemicals Ltd as on 20 April 2025 is 195.

What is the High / Low of Chemcon Speciality Chemicals Ltd stocks in FY 2025-2026?

In FY 2025-2026, the High / Low of Chemcon Speciality Chemicals Ltd stocks is ₹298/160.

What is the Stock P/E of Chemcon Speciality Chemicals Ltd?

The Stock P/E of Chemcon Speciality Chemicals Ltd is 30.5.

What is the Book Value of Chemcon Speciality Chemicals Ltd?

The Book Value of Chemcon Speciality Chemicals Ltd is 133.

What is the Dividend Yield of Chemcon Speciality Chemicals Ltd?

The Dividend Yield of Chemcon Speciality Chemicals Ltd is 0.00 %.

What is the ROCE of Chemcon Speciality Chemicals Ltd?

The ROCE of Chemcon Speciality Chemicals Ltd is 5.71 %.

What is the ROE of Chemcon Speciality Chemicals Ltd?

The ROE of Chemcon Speciality Chemicals Ltd is 4.11 %.

What is the Face Value of Chemcon Speciality Chemicals Ltd?

The Face Value of Chemcon Speciality Chemicals Ltd is 10.0.